Literature DB >> 28289095

Contribution of type III interferons to antiviral immunity: location, location, location.

Sergei V Kotenko1,2,3, Joan E Durbin4,3,5.   

Abstract

Type I interferons (IFN-α/β) and the more recently identified type III IFNs (IFN-λ) function as the first line of defense against virus infection and regulate the development of both innate and adaptive immune responses. Type III IFNs were originally identified as a novel ligand-receptor system acting in parallel with type I IFNs, but subsequent studies have provided increasing evidence for distinct roles for each IFN family. In addition to their compartmentalized antiviral actions, these two systems appear to have multiple levels of cross-regulation and act coordinately to achieve effective antimicrobial protection with minimal collateral damage to the host.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  antiviral agent; interferon; mucosal immunology; viral immunology; virology

Mesh:

Substances:

Year:  2017        PMID: 28289095      PMCID: PMC5418032          DOI: 10.1074/jbc.R117.777102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  Cut, copy, move, delete: The study of human interferon genes reveal multiple mechanisms underlying their evolution in amniotes.

Authors:  Christopher D Krause; Sidney Pestka
Journal:  Cytokine       Date:  2015-07-27       Impact factor: 3.861

3.  HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.

Authors:  Emmanuel Thomas; Veronica D Gonzalez; Qisheng Li; Ankit A Modi; Weiping Chen; Mazen Noureddin; Yaron Rotman; T Jake Liang
Journal:  Gastroenterology       Date:  2012-01-13       Impact factor: 22.682

4.  Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Authors:  Ewa Terczyńska-Dyla; Stephanie Bibert; Francois H T Duong; Ilona Krol; Sanne Jørgensen; Emilie Collinet; Zoltán Kutalik; Vincent Aubert; Andreas Cerny; Laurent Kaiser; Raffaele Malinverni; Alessandra Mangia; Darius Moradpour; Beat Müllhaupt; Francesco Negro; Rosanna Santoro; David Semela; Nasser Semmo; Markus H Heim; Pierre-Yves Bochud; Rune Hartmann
Journal:  Nat Commun       Date:  2014-12-23       Impact factor: 14.919

5.  Human interferon-lambda3 is a potent member of the type III interferon family.

Authors:  C Dellgren; H H Gad; O J Hamming; J Melchjorsen; R Hartmann
Journal:  Genes Immun       Date:  2008-11-06       Impact factor: 2.676

6.  IFNL cytokines do not modulate human or murine NK cell functions.

Authors:  Maria H Morrison; Ciara Keane; Louise M Quinn; Aoife Kelly; Cliona O'Farrelly; Colm Bergin; Clair M Gardiner
Journal:  Hum Immunol       Date:  2014-06-30       Impact factor: 2.850

7.  Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.

Authors:  Nikolaus Jilg; Wenyu Lin; Jian Hong; Esperance A Schaefer; David Wolski; James Meixong; Kaku Goto; Cynthia Brisac; Pattranuch Chusri; Dahlene N Fusco; Stephane Chevaliez; Jay Luther; Kattareeya Kumthip; Thomas J Urban; Lee F Peng; Georg M Lauer; Raymond T Chung
Journal:  Hepatology       Date:  2014-02-14       Impact factor: 17.425

8.  Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.

Authors:  Shuye Zhang; Karen Kodys; Kui Li; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2012-10-23       Impact factor: 22.682

9.  Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.

Authors:  Hélène Bierne; Laetitia Travier; Tanel Mahlakõiv; Ludovic Tailleux; Agathe Subtil; Alice Lebreton; Anupam Paliwal; Brigitte Gicquel; Peter Staeheli; Marc Lecuit; Pascale Cossart
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

10.  Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.

Authors:  Ahmad Amanzada; Waltraut Kopp; Ulrich Spengler; Giuliano Ramadori; Sabine Mihm
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  50 in total

Review 1.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

Review 2.  Interferon Lambda's New Role as Regulator of Neutrophil Function.

Authors:  Amariliz Rivera
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

Review 3.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 4.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

5.  Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine Platform.

Authors:  Anthony M Marchese; Carolina Chiale; Safiehkhatoon Moshkani; Michael D Robek
Journal:  J Interferon Cytokine Res       Date:  2019-10-18       Impact factor: 2.607

Review 6.  Shared and Distinct Functions of Type I and Type III Interferons.

Authors:  Helen M Lazear; John W Schoggins; Michael S Diamond
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

7.  Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.

Authors:  Rishi R Goel; Xinghao Wang; Liam J O'Neil; Shuichiro Nakabo; Kowser Hasneen; Sarthak Gupta; Gustaf Wigerblad; Luz P Blanco; Jeffrey B Kopp; Maria I Morasso; Sergei V Kotenko; Zu-Xi Yu; Carmelo Carmona-Rivera; Mariana J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

8.  Differential Induction of Type I and III Interferons by Staphylococcus aureus.

Authors:  Adeline Peignier; Paul J Planet; Dane Parker
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 9.  The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus.

Authors:  Timothy J Nice; Bridget A Robinson; Jacob A Van Winkle
Journal:  Trends Microbiol       Date:  2017-11-17       Impact factor: 17.079

10.  Type III interferon is a critical regulator of innate antifungal immunity.

Authors:  Vanessa Espinosa; Orchi Dutta; Constance McElrath; Peicheng Du; Yun-Juan Chang; Bryan Cicciarelli; Amy Pitler; Ian Whitehead; Joshua J Obar; Joan E Durbin; Sergei V Kotenko; Amariliz Rivera
Journal:  Sci Immunol       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.